Immediate Impact
56 standout
Citing Papers
Ponsegromab for the Treatment of Cancer Cachexia
2024 Standout
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
Works of Müjde Aktürk being referenced
GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance
2016
Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancer
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Müjde Aktürk | 399 | 184 | 212 | 197 | 78 | 1.1k | |
| İlhan Yetkin | 432 | 142 | 322 | 155 | 91 | 1.4k | |
| Alpaslan Tuzcu | 409 | 137 | 133 | 183 | 65 | 1.1k | |
| Alev Eroğlu Altınova | 365 | 132 | 197 | 208 | 72 | 1.0k | |
| Evin Ademoğlu | 291 | 289 | 176 | 195 | 65 | 1.3k | |
| Nuri Çakır | 368 | 127 | 261 | 187 | 60 | 1.4k | |
| Marina Shargorodsky | 282 | 130 | 221 | 192 | 53 | 1.2k | |
| Roberto Mioni | 456 | 110 | 229 | 96 | 54 | 1.2k | |
| Masayo Yamada | 379 | 121 | 290 | 199 | 61 | 1.3k | |
| George Christodoulakos | 370 | 88 | 131 | 74 | 55 | 1.2k | |
| Sema Akalın | 468 | 266 | 131 | 185 | 51 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...